Moc-31, fibronectin and CEA in the differential diagnosis of malignant effusions: An immunocytochemical study

Pathology and Oncology Research

Volumn 6, Issue 2, 2000, Pages 100-103

  Athanassiadou, Pauline ^a   Gonidi, Maria ^a   Liossi, Anna ^a   Petrakakou, Efthalia ^a   Nakopoulou, Lydia ^a   Zerva, Cherry ^a   Athanassiades, Peter ^b  

^a ALEXANDRA HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

CEA; Effusions; Fibronectin; Immunocytochemistry; MOC 31; Reactive atypical mesothelial cells

Indexed keywords

ANTIBODY; CARCINOEMBRYONIC ANTIGEN; FIBRONECTIN; MEMBRANE PROTEIN;

ARTICLE; CONTROLLED STUDY; EFFUSION; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE;

EID: 0033846712     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03032357     Document Type: Article

References (2)

1. Bedrossian CWM: Malignant effusions: A multimodal approach to cytologic diagnosis. New York, Igaku-Shoin Medical Publishers, 1994.
2. de Leij L, Broers J, Ramackers F, et al. Monoclonal antibodies in clinical and experimental pathology of lung cancer. In: Ruiter DJ, Fleuren GJ, Warnaar SO, eds. Application of Monoclonal Antibodies in Tumor Pathology. Dordrecht, the Netherlands: Martinus Nijhoff Publishers, 1987:191-207.